COMPOUNDS
Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and conditions, skin conditions and ocular conditions.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
02.08.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and conditions, skin conditions and ocular conditions. |
|---|---|
| AbstractList | Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and conditions, skin conditions and ocular conditions. |
| Author | HAY, Duncan Alexander MCCARTHY, Clive SCHOFIELD, Thomas Beauregard |
| Author_xml | – fullname: MCCARTHY, Clive – fullname: HAY, Duncan Alexander – fullname: SCHOFIELD, Thomas Beauregard |
| BookMark | eNrjYmDJy89L5WTgdPb3DfAP9XMJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxuaWJgYGRk6GxkQoAQDDXB0C |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSÉS VERBINDUNGEN |
| ExternalDocumentID | EP3794002B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3794002B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 26 04:42:02 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3794002B13 |
| Notes | Application Number: EP20190726121 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230802&DB=EPODOC&CC=EP&NR=3794002B1 |
| ParticipantIDs | epo_espacenet_EP3794002B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230802 |
| PublicationDateYYYYMMDD | 2023-08-02 |
| PublicationDate_xml | – month: 08 year: 2023 text: 20230802 day: 02 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Enterprise Therapeutics Limited |
| RelatedCompanies_xml | – name: Enterprise Therapeutics Limited |
| Score | 3.477763 |
| Snippet | Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | COMPOUNDS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230802&DB=EPODOC&locale=&CC=EP&NR=3794002B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUg0T0uzSDXQTTa3SNM1sUgC3QZokqwLGvE3AB2_bpkEGof09TPzCDXxijCNYGLIhO2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmrQ3jGwPW1hYKTm4mTrGuDv4u-s5uwMZKn5Bdkam4NuADdyAnaUWEGtaNAx-65hTqBNKQXINYqbIANbANCwvBIhBqbUPGEGTmfYxWvCDBy-0PluIBOa9YpFgCr8fQP8Q_1cgkUZFNxcQ5w9dIFmxsPdH-8aALfdWIyBBditT5VgUEhONjZPSQQdmZZkbGKSYmlhmJqSbGGaZJZmAqyyDc0lGSRxGiOFR06agQsUEOBFakYyDCwlRaWpssCKsyRJDuxlACrebvE |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUg0T0uzSDXQTTa3SNM1sUgC3QZokqwLGvE3AB2_bpkEGof09TPzCDXxijCNYGLIhO2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmrQ3jGwPW1hYKTm4mTrGuDv4u-s5uwMZKn5Bdkam4NuADdyAnaUWM1Bh_OCWk5hTqBNKQXINYqbIANbANCwvBIhBqbUPGEGTmfYxWvCDBy-0PluIBOa9YpFgCr8fQP8Q_1cgkUZFNxcQ5w9dIFmxsPdH-8aALfdWIyBBditT5VgUEhONjZPSQQdmZZkbGKSYmlhmJqSbGGaZJZmAqyyDc0lGSRxGiOFR06egdMjxNcn3sfTz1uagQsUKOAFa0YyDCwlRaWpssBKtCRJDux9AIJXcd4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS&rft.inventor=MCCARTHY%2C+Clive&rft.inventor=HAY%2C+Duncan+Alexander&rft.inventor=SCHOFIELD%2C+Thomas+Beauregard&rft.date=2023-08-02&rft.externalDBID=B1&rft.externalDocID=EP3794002B1 |